6 years ago
Kansas State University researchers, in collaboration with researchers at the University of Texas Medical Branch, have received $2 million in funding from the National Science Foundation Emerging Frontiers in Research and Innovation program to conduct fundamental studies on new treatments for glioblastoma and other cancers.
Led by Stefan Bossmann, university distinguished professor of chemistry, the group ...